By using a mouse model of AIH induced by IV administration of concanavalin A and a mechanistic PK/PD modeling approach, selective PDE3, PDE4, and PDE7 inhibitors, as well as non-selective PDE inhibitors, were evaluated as potential medications for AIH [41,79]. The gene discussed is PDE7A; the disease is autoimmune hepatitis.